Literature DB >> 25701076

Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.

Yin-Hu Wang1, Wei Yang2, Jing-Bo Yang3, Yan-Jie Jia4, Wei Tang5, M Eric Gershwin6, William M Ridgway7, Zhe-Xiong Lian8.   

Abstract

CD4(+)Foxp3(+) regulatory T cells (Tregs) play a non-redundant role in control of excessive immune responses, and defects in Tregs have been shown both in patients and murine models of primary biliary cirrhosis (PBC), a progressive autoimmune biliary disease. Herein, we took advantage of a murine model of PBC, the dominant negative transforming growth factor β receptor II (dnTGFβRII) mice, to assess Treg genetic defects and their functional effects in PBC. By using high-resolution microarrays with verification by PCR and protein expression, we found profound and wide-ranging differences between dnTGFβRII and normal, wild type Tregs. Critical transcription factors were down-regulated including Eos, Ahr, Klf2, Foxp1 in dnTGFβRII Tregs. Functionally, dnTGFβRII Tregs expressed an activated, pro-inflammatory phenotype with upregulation of Ccl5, Granzyme B and IFN-γ. Genetic pathway analysis suggested that the primary effect of loss of TGFβ pathway signaling was to down regulate immune regulatory processes, with a secondary upregulation of inflammatory processes. These findings provide new insights into T regulatory genetic defects; aberrations of the identified genes or genetic pathways should be investigated in human PBC Tregs. This approach which takes advantage of biologic pathway analysis illustrates the ability to identify genes/pathways that are affected both independently and dependent on abnormalities in TGFβ signaling. Such approaches will become increasingly useful in human autoimmunity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangitis; Primary biliary cirrhosis; Regulatory T cells; Transcription profile and pathway analysis

Mesh:

Substances:

Year:  2015        PMID: 25701076      PMCID: PMC4829434          DOI: 10.1016/j.jaut.2015.01.011

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  45 in total

1.  Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice.

Authors:  Yuan Yao; Wei Yang; Yan-Qing Yang; Hong-Di Ma; Fang-Ting Lu; Liang Li; Yan-Yan Tao; Koichi Tsuneyama; Weici Zhang; Scott Friedman; M Eric Gershwin; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2014-03-17       Impact factor: 7.094

2.  The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells.

Authors:  Haikun Wang; Jianlin Geng; Xiaomin Wen; Enguang Bi; Andrew V Kossenkov; Amaya I Wolf; Jeroen Tas; Youn Soo Choi; Hiroshi Takata; Timothy J Day; Li-Yuan Chang; Stephanie L Sprout; Emily K Becker; Jessica Willen; Lifeng Tian; Xinxin Wang; Changchun Xiao; Ping Jiang; Shane Crotty; Gabriel D Victora; Louise C Showe; Haley O Tucker; Jan Erikson; Hui Hu
Journal:  Nat Immunol       Date:  2014-05-25       Impact factor: 25.606

3.  Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells.

Authors:  H Tanaka; W Zhang; G-X Yang; Y Ando; T Tomiyama; K Tsuneyama; P Leung; R L Coppel; A A Ansari; Z X Lian; W M Ridgway; T Joh; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

4.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

5.  Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.

Authors:  Kazuhito Kawata; Guo-Xiang Yang; Yugo Ando; Hajime Tanaka; Weici Zhang; Yoshimasa Kobayashi; Koichi Tsuneyama; Patrick S C Leung; Zhe-Xiong Lian; William M Ridgway; Aftab A Ansari; Xiao-Song He; M Eric Gershwin
Journal:  Hepatology       Date:  2013-07-24       Impact factor: 17.425

6.  Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

Authors:  S P Kar; M F Seldin; W Chen; E Lu; G M Hirschfield; P Invernizzi; J Heathcote; D Cusi; M E Gershwin; K A Siminovitch; C I Amos
Journal:  Genes Immun       Date:  2013-02-07       Impact factor: 2.676

7.  KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production.

Authors:  Sudheer K Pabbisetty; Whitney Rabacal; Damian Maseda; Delphine Cendron; Patrick L Collins; Kristen L Hoek; Vrajesh V Parekh; Thomas M Aune; Eric Sebzda
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

8.  IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.

Authors:  Chen-Yen Yang; Xiong Ma; Koichi Tsuneyama; Shanshan Huang; Toru Takahashi; Naga P Chalasani; Christopher L Bowlus; Guo-Xiang Yang; Patrick S C Leung; Aftab A Ansari; Linda Wu; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

9.  Differential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.

Authors:  Wei Yang; Yuan Yao; Yan-Qing Yang; Fang-Ting Lu; Liang Li; Yin-Hu Wang; Takahiko Nakajima; Koichi Tsuneyama; William M Ridgway; M Eric Gershwin; Zhe-Xiong Lian
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

10.  Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells.

Authors:  Aaron Arvey; Joris van der Veeken; Robert M Samstein; Yongqiang Feng; John A Stamatoyannopoulos; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2014-04-13       Impact factor: 25.606

View more
  28 in total

1.  Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy.

Authors:  Jing-Bo Yang; Yin-Hu Wang; Wei Yang; Fang-Ting Lu; Hong-Di Ma; Zhi-Bin Zhao; Yan-Jie Jia; Wei Tang; Koichi Tsuneyama; William M Ridgway; M Eric Gershwin; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2015-10-01       Impact factor: 7.094

Review 2.  A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.

Authors:  Laurent Ehrlich; Chad Hall; Fanyin Meng; Terry Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Gene Expr       Date:  2017-04-28

Review 3.  Geoepidemiology and changing mortality in primary biliary cholangitis.

Authors:  Annarosa Floreani; Atsushi Tanaka; Christopher Bowlus; Merrill Eric Gershwin
Journal:  J Gastroenterol       Date:  2017-04-01       Impact factor: 7.527

4.  Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation.

Authors:  Hong-Di Ma; Wen-Tao Ma; Qing-Zhi Liu; Zhi-Bin Zhao; Mu-Zi-Ying Liu; Koichi Tsuneyama; Jin-Ming Gao; William M Ridgway; Aftab A Ansari; M Eric Gershwin; Yun-Yun Fei; Zhe-Xiong Lian
Journal:  J Autoimmun       Date:  2017-01-24       Impact factor: 7.094

5.  Liver-resident NK cells suppress autoimmune cholangitis and limit the proliferation of CD4+ T cells.

Authors:  Zhi-Bin Zhao; Fang-Ting Lu; Hong-Di Ma; Yin-Hu Wang; Wei Yang; Jie Long; Qi Miao; Weici Zhang; Zhigang Tian; William M Ridgway; Jie Cao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

6.  The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis.

Authors:  Takashi Tomiyama; Guo-Xiang Yang; Ming Zhao; Weici Zhang; Hajime Tanaka; Jing Wang; Patrick Sc Leung; Kazuichi Okazaki; Xiao-Song He; Qianjin Lu; Ross L Coppel; Christopher L Bowlus; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

Review 7.  Proposed therapies in primary biliary cholangitis.

Authors:  Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2016-01-06       Impact factor: 3.869

8.  The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.

Authors:  Fan Yang; Qixia Wang; Zhaoyue Wang; Qi Miao; Xiao Xiao; Ruqi Tang; Xiaoyu Chen; Zhaolian Bian; Haiyan Zhang; Yue Yang; Li Sheng; Jingyuan Fang; Dekai Qiu; Edward L Krawitt; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

9.  Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.

Authors:  G-X Yang; Y Sun; K Tsuneyama; W Zhang; P S C Leung; X-S He; A A Ansari; C Bowlus; W M Ridgway; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

Review 10.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.